Safety and Tolerability of Thrombin Inhibition in Scleroderma-Associated Interstitial Lung Disease.

Silver, R M; Wilson, D A; Akter, T; Atanelishvili, I; Huggins, J T; Kajdasz, K; Highland, K B; Nietert, P J; Bogatkevich, G S

Silver, R M; Wilson, D A; Akter, T; Atanelishvili, I; Huggins, J T; Kajdasz, K; Highland, K B; Nietert, P J; Bogatkevich, G S.

Afiliación

Silver RM; Medical University of South Carolina Charleston.
Wilson DA; Medical University of South Carolina Charleston.
Akter T; Medical University of South Carolina Charleston.
Atanelishvili I; Medical University of South Carolina Charleston.
Huggins JT; Medical University of South Carolina Charleston.
Kajdasz K; Medical University of South Carolina Charleston.
Highland KB; Cleveland Clinic Cleveland Ohio.
Nietert PJ; Medical University of South Carolina Charleston.
Bogatkevich GS; Medical University of South Carolina Charleston.

ACR Open Rheumatol ; 1(7): 403-411, 2019 Sep.

Article en En | MEDLINE | ID: mdl-31777820

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Clinical_trials / Risk_factors_studies Aspecto: Patient_preference Idioma: En Revista: ACR Open Rheumatol Año: 2019 Tipo del documento: Article Pais de publicación: Estados Unidos

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google